1. Home
  2. PRAX vs LLYVA Comparison

PRAX vs LLYVA Comparison

Compare PRAX & LLYVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$345.30

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo Liberty Media Corporation Series A Liberty Live

LLYVA

Liberty Media Corporation Series A Liberty Live

HOLD

Current Price

$93.66

Market Cap

9.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
LLYVA
Founded
2015
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
9.2B
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
PRAX
LLYVA
Price
$345.30
$93.66
Analyst Decision
Strong Buy
Analyst Count
15
0
Target Price
$572.13
N/A
AVG Volume (30 Days)
311.4K
93.0K
Earning Date
05-08-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$381,951,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7,758.26
$5.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
12.18
52 Week Low
$37.25
$74.38
52 Week High
$392.70
$106.06

Technical Indicators

Market Signals
Indicator
PRAX
LLYVA
Relative Strength Index (RSI) 47.08 35.98
Support Level $285.26 $93.31
Resistance Level $356.02 $99.16
Average True Range (ATR) 17.13 2.12
MACD -4.00 -0.93
Stochastic Oscillator 21.92 3.97

Price Performance

Historical Comparison
PRAX
LLYVA

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About LLYVA Liberty Media Corporation Series A Liberty Live

Liberty Live Holdings Inc consists of its ownership in Live Nation, its wholly owned subsidiary Quint and other minority investments. Quint is a provider of premium sports and entertainment experiences. Through exclusive rights agreements with sports leagues, event organizers, and governing bodies, Quint designs, develops, and sells official ticket-inclusive hospitality and single to multi-day experiential packages that may include on or off-site experiences, transportation, and hotel accommodations, with involvement of Quint personnel throughout the multi-day experiences. Live Nation is one of the live entertainment companies in the world, and the producer of live music concerts in the world, based on total fans that attend Live Nation events as compared to events of other promoters.

Share on Social Networks: